Literature DB >> 12840871

Expression of adherent molecule and cyclin by ligustrazine in bone marrow of mice with immune-induced aplastic anemia.

L Dong1, H Sun, W Liu, H Xu, D Tao.   

Abstract

Mice with immune-induced aplastic anemia (AA) were given 5 mg ligustrazine intraperitoneally twice a day. On the 14th day, the expression of CD49d, CD49c, cyclinD2 in bone marrow mononuclear cells (MNC) was examined by flow cytometry, and VCAM-1 on stromal cells was immunohistochemically measured by Strept Avidin-Biotin Complex (SABC). The expression of CD49d, CD49c, VCAM-1 and cyclinD2 in ligustrazine-treated group was significantly higher than that in AA group (P < 0.01), but the ratio of G0 + G1 phase cells was significantly lower than that in AA group (P < 0.01). The results showed that ligustrazine could improve the expression of adherent molecule and cyclin D2 in the bone marrow of mice with immune-induced aplastic anemia, thereby promoting the growth of hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12840871     DOI: 10.1007/bf02895590

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  4 in total

Review 1.  Expression and function of integrins on hematopoietic progenitor cells.

Authors:  L Coulombel; I Auffray; M H Gaugler; M Rosemblatt
Journal:  Acta Haematol       Date:  1997       Impact factor: 2.195

2.  Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression.

Authors:  G Radeva; T Petrocelli; E Behrend; C Leung-Hagesteijn; J Filmus; J Slingerland; S Dedhar
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

3.  Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry.

Authors:  J Gong; U Bhatia; F Traganos; Z Darzynkiewicz
Journal:  Leukemia       Date:  1995-05       Impact factor: 11.528

4.  Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells.

Authors:  K Ando; F Ajchenbaum-Cymbalista; J D Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.